The ability to stimulate functional neuronal regeneration would markedly enhance treatment of brain injuries and neurodegenerative diseases. In studies of C. elegans, Pinan-Lucarre et al. uncovered unexpected roles for apoptotic proteins in promoting neuronal regeneration that might be conserved across species. Worms mutant for CED-3, the core executioner apoptotic protease in C. elegans, had slower axonal outgrowth and delayed neuronal reconnections after laser-mediated injury. The CED-3-activating protein CED-4 [homologue of mammalian apoptosis protease activating factor-1 (Apaf-1)], but not other upstream apoptotic proteins, was also important. They also linked CED-3 and CED-4 to a pathway involving DLK-1, a kinase implicated in regeneration across species. Finally, they showed that this regenerative pathway involves Ca2+ signalling (known to be important in neuronal responses to injury) and specifically the conserved Ca2+-binding protein calreticulin. The authors propose a model whereby injury-induced Ca2+ signalling amplified by calreticulin promotes CED-4-mediated activation of CED-3, which then acts upstream of a DLK-1-mediated regenerative pathway. These data uncover a previously unknown pathway that will guide future studies of neuronal regeneration in higher organisms.
Neuronal regeneration: a role for apoptotic proteins
Neuronal regeneration: a role for apoptotic proteins. Dis Model Mech 1 July 2012; 5 (4): 415. doi:
Download citation file:
Advertisement
Cited by
DMM Journal Meeting 2024: Pre-clinical Modelling of Human Genetic Disease and Therapy

Register your interest for our 2024 Journal Meeting. Rapid advances in gene editing and genetic technologies have revolutionised our ability to model human genetic disease and provided new hope for gene therapies. At this Meeting, we will present the very latest advances in modelling human genetic disease. Find more information here.
A new call for papers is underway

Showcase your latest research in our upcoming special issue Translating Multiscale Research in Rare Disease, coordinated by DMM Editors Monica Justice, Karen Liu and Monkol Lek, and Guest Editor Kate Rauen. The deadline for submitting articles to the special issue is Monday 6 November 2023.
Moving towards heart success – Disease Models & Mechanisms Special Issue

DMM's most recent special issue compiles articles that aim to move heart failure to heart success by fundamentally addressing the roots of failure to identify curative strategies.
Adult zebrafish as advanced models of human disease

Editor-in-Chief Liz Patton and Editorial Board member Rich White discuss the unique advantages of adult zebrafish for studying human disease biology. Read the Open Access Editorial here.
The Forest of Biologists

The Forest of Biologists is a biodiversity initiative created by The Company of Biologists, with support from the Woodland Trust. For every Research and Review article published in Disease Models & Mechanisms a native tree is planted in a UK forest. In addition to this we are protecting and restoring ancient woodland and are dedicating these trees to our peer reviewers. Visit our virtual forest to learn more.
Other journals from
The Company of Biologists